13LBA Improved overall survival by adding regional hyperthermia to neo-adjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): Long-term outcomes of the EORTC 62961/ESHO randomized phase III study

Autor: Issels, R.D., Lindner, L.H., Ghadjar, P., Reichardt, P., Hohenberger, P., Verweij, J., Abdel-Rahman, S., Daugaard, S., Salat, C., Vujaskovic, Z., Wessalowski, R., Duerr, H.R., Ploner, F., Mella, O., Schmidt, M., Mansmann, U., Jauch, K.W., Belka, C., Hiddemann, W., Gronchi, A.
Zdroj: In European Journal of Cancer September 2015 51 Supplement 3:S716-S716
Databáze: ScienceDirect
Externí odkaz: